US Broker Ratings

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: A 191% Upside Potential in the Biotech Arena

Gyre Therapeutics, Inc. (NASDAQ: GYRE) is garnering attention in the biotechnology sector with its focus on developing and commercializing groundbreaking small-molecule anti-inflammatory and anti-fibrotic drugs. With..

Nutex Health Inc. (NUTX) Stock Analysis: A Strategic Play in Healthcare with a 62% Upside Potential

Nutex Health Inc. (NUTX), a key player in the healthcare sector specializing in medical care facilities, is catching the eye of investors with its substantial upside..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Exploring Its 34.13% Potential Upside in a Competitive Biotech Landscape

Arcus Biosciences, Inc. (NASDAQ: RCUS) is positioned in the dynamic biotechnology sector, a field known for its potential high-reward opportunities but also substantial risks. With a..

CareDx, Inc. (CDNA) Stock Analysis: Strong Revenue Growth and Investor Optimism Signal Potential Upside

CareDx, Inc. (NASDAQ: CDNA), a prominent player in the healthcare diagnostics and research industry, is catching the eyes of investors due to its robust revenue growth..

Phibro Animal Health Corporation (PAHC) Stock Analysis: A Closer Look at a 26.76% Upside Potential

Phibro Animal Health Corporation (NASDAQ: PAHC), a prominent player in the healthcare sector under the specialty and generic drug manufacturing industry, presents an intriguing opportunity for..

Evolent Health, Inc (EVH)

⚠️ No article content returned.

..

Harrow, Inc. (HROW) Stock Analysis: Exploring the 73% Upside Potential for This Eyecare Innovator

Investors with an eye for potential growth opportunities may want to take a closer look at Harrow, Inc. (NASDAQ: HROW), a dynamic player in the healthcare..

Azenta, Inc. (AZTA) Stock Analysis: Navigating Growth in the Life Sciences Sector

Azenta, Inc. (NASDAQ: AZTA), a notable player in the healthcare sector, operates within the medical instruments and supplies industry, offering a comprehensive portfolio of biological and..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Evaluating a 14.48% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG) stands at the intersection of healthcare and essential services, providing critical management and operational support to medical care facilities across..

Integra LifeSciences Holdings C (IART) Investor Outlook: Target Price Hints at 9.37% Upside Potential

Integra LifeSciences Holdings Corporation (NASDAQ: IART) presents a compelling opportunity for investors eyeing the healthcare sector, specifically the dynamic field of medical devices. With a market..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: A Look at Growth Potential and Strategic Positioning

Pacira BioSciences, Inc. (NASDAQ: PCRX), a notable player in the healthcare sector, specializes in the development and commercialization of non-opioid pain management solutions. As the opioid..

MannKind Corporation (MNKD) Stock Analysis: Investor Outlook on a Biotech with Over 100% Potential Upside

MannKind Corporation (NASDAQ: MNKD), a dynamic player in the biotechnology sector, is catching the attention of investors with its promising growth trajectory and innovative solutions for..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Navigating Growth with Precision in the Healthcare Sector

BioLife Solutions, Inc. (NASDAQ: BLFS), a prominent player in the healthcare sector, specializes in developing and marketing critical bioproduction products and services for the cell and..

Teladoc Health, Inc. (TDOC) Stock Analysis: Exploring a 16% Upside Potential Amidst Revenue Challenges

Teladoc Health, Inc. (NASDAQ: TDOC) has been a transformative force in the healthcare sector, offering a wide array of virtual healthcare services. With its headquarters in..

NeoGenomics, Inc. (NEO): Investor Outlook with a Spotlight on 24.51% Potential Upside

NeoGenomics, Inc. (NASDAQ: NEO) is making waves in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $2.06 billion, this..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Unpacking a 241.90% Potential Upside

Wave Life Sciences Ltd. (NASDAQ: WVE), a biotechnology firm based in Singapore, operates at the cutting edge of RNA medicine development. The company’s focus on designing..

Immunocore Holdings plc (IMCR) Investor Outlook: Exploring a Potential 96% Upside in Biotech Innovation

Immunocore Holdings plc (NASDAQ: IMCR) stands at the forefront of the biotechnology industry, making waves with its innovative approaches to immunotherapy. With a market cap of..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Exploring a 222% Upside Potential in Biotech Innovation

Investors with an eye on emerging biotechnologies may want to take a closer look at Ocular Therapeutix, Inc. (NASDAQ: OCUL), a company making significant strides in..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: A Promising Healthcare Play with 8.74% Upside Potential

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) represents an intriguing opportunity for investors looking to tap into the healthcare sector. With a market capitalization of $2.09 billion..

The Pennant Group, Inc. (PNTG) Stock Analysis: A Healthy 12% Upside Potential for Investors

The Pennant Group, Inc. (NASDAQ: PNTG), a healthcare services provider based in Eagle, Idaho, has been making waves in the medical care facilities industry. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds